Status:
RECRUITING
Omega-3 Fatty Acids and Nutritional Support in Gastrointestinal Cancer
Lead Sponsor:
Maimónides Biomedical Research Institute of Córdoba
Conditions:
Sarcopenia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Sarcopenia is a frequent complication in patients with cancer and chronic diseases, it is characterized by decreased muscle strength and fatigue due to reduced skeletal muscle mass, which is accompani...
Eligibility Criteria
Inclusion
- \- Patients with Gastrointestinal tumor undergoing systemic treatment (chemo-radio-immuno therapy or their combination)
- Body weight loss \>5% in the previous three months or \>10% in the previous six months
- Both sexes
- Age between 18-85 y-old.
Exclusion
- Life expectancy \< 2 weeks
- MDRD \< 15 mL/min
- End-stage liver disease
- Any musculoskeletal, cardiovascular and/or neurological disorders that could affect exercising.
Key Trial Info
Start Date :
July 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06015971
Start Date
July 1 2023
End Date
December 31 2026
Last Update
May 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IMIBIC
Córdoba, Cordoba, Spain, 14004